Opus Genetics Inc
NASDAQ:IRD
Intrinsic Value
The intrinsic value of one
IRD
stock under the Base Case scenario is
0.62
USD.
Compared to the current market price of 1.92 USD,
Opus Genetics Inc
is
Overvalued by 68%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Opus Genetics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Opus Genetics Inc
Balance Sheet Decomposition
Opus Genetics Inc
| Current Assets | 38.4m |
| Cash & Short-Term Investments | 32.4m |
| Receivables | 4.6m |
| Other Current Assets | 1.4m |
| Non-Current Assets | 226k |
| PP&E | 226k |
Free Cash Flow Analysis
Opus Genetics Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Opus Genetics Inc
|
Revenue
|
15.4m
USD
|
|
Operating Expenses
|
-49.9m
USD
|
|
Operating Income
|
-34.5m
USD
|
|
Other Expenses
|
-23.8m
USD
|
|
Net Income
|
-58.3m
USD
|
IRD Profitability Score
Profitability Due Diligence
Opus Genetics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
Opus Genetics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
IRD Solvency Score
Solvency Due Diligence
Opus Genetics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
Opus Genetics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IRD Price Targets Summary
Opus Genetics Inc
According to Wall Street analysts, the average 1-year price target for
IRD
is 6.94 USD
with a low forecast of 5.05 USD and a high forecast of 9.45 USD.
Dividends
Current shareholder yield for
IRD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IRD
stock under the Base Case scenario is
0.62
USD.
Compared to the current market price of 1.92 USD,
Opus Genetics Inc
is
Overvalued by 68%.